Immunoassay Analyzers Market Research Report- Forecast till 2030

Immunoassay Analyzers Market Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Forecast till 2030

ID: MRFR/MED/0694-HCR | 80 Pages | Published By Kinjoll Dey on March 2023         

Immunoassay Analyzers Market Speak to Analyst Request a Free Sample

Immunoassay Analyzers Market

Immunoassay Analyzers Market is projected to be worth USD 1,588.16 Millionby 2030, registering a CAGR of 5.40% during the forecast period (2022-2030).

Segmentation
By Instruments Immunofluorescence Chemiluminescence ELISA Radioimmunoassay
By Application Infectious Diseases Autoimmune Diseases AIDS
By End-User Hospitals
Key Players
Companies Profiled   F. Hoffmann-La Roche Ltd. (Switzerland)   Siemens Ltd. (Germany)   Abbott (US)   Beckman Coulter Inc. (US)   Ortho Clinical Diagnostics (US)   bioMérieux Private Limited (France)   Biokit S.A (Spain)   The Binding Site Group Ltd. (UK)   Immunodiagnostic Systems (UK)   Merck KGaA (US)   Olympus Corporation (Japan)   Nova Century Scientific Inc. (US)   Thermo Fisher Scientific (US)   DiaSorin S.p.A. (Italy)   Randox Laboratories Ltd. (UK).
Drivers
Market Driving Forces   Increasing prevalence of different infectious immunological or metabolic diseases   Increasing demand of advanced diagnostic devices and recent trends of automation and integration
Request a Free Sample

Immunoassay Analyzers Market Scenario


The Immunoassay Analyzers Market is anticipated to reach USD 1,588.16 Million by 2030 at 5.40% CAGR during the forecast period 2022-2030.Immunoassay is a test that measures the concentration of analytes in blood samples, this is done by an instrument known as immunoassay analyzer. This instrument measures the presence or concentration of proteins in analyte samples; using antigen-antibody binding properties. Increasing demand for the new and better drugs has led to increase the number of testing procedures. These assays are used to monitor and measure different types of diseases. The immunoassay analyzer market is majorly driven by an increasing prevalence of different infectious, immunological or metabolic diseases, increasing demand of advanced diagnostic devices and recent trends of automation and integration which together have led to the introduction of innovative products in immunoassay analyzer market. According to the Center of Disease Control and Prevention, over 17.8 million people suffers from infectious diseases each year. Beside this, rising number of patient suffering from cardiovascular diseases and diabetes has stimulated the demand for the different drugs and tests ultimately led to the growth of the immunoassay analyzer market. Furthermore, increasing geriatric population, changing lifestyle, growing habit of smoking and drinking along with increasing spending on healthcare have also fuelled the growth of immunoassay analyzer market. However, test and assays performed are strictly monitor and thus, strict regulatory requirement and high cost of the instruments may hinder this market’s growth.


Intended Audience



  • Immunoassay Analyzers Manufacturer

  • Immunoassay Analyzers Supplier

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Figure 1- Global immunoassay analyzers market, by application Immunoassay Analyzers Market


Source- Annual reports, press release, white paper, company presentation 


Segmentation


The immunoassay analyzer immunoassay analyzer market is segmented on the basis of instruments, applications, and end users.


On the basis of instruments, the immunoassay analyzer market is classified into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent system, multiplexed assay system, radioimmunoassay and others.


On the basis of application, the immunoassay analyzer market is segmented into infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others.


On the basis of end users, the immunoassay analyzer market is categorized into hospitals, diagnostic laboratories, research institutes, and others. 


Regional Analysis


America dominates the immunoassay analyzer market owing to large patient population and strong government support. Increasing diabetic population has also contributed in the growth of the immunoassay analyzer market market.  According to the WHO, in 2016, 9.6% of total America population were suffering from diabetes. In addition to this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. Government and many companies are conducting many seminar in order to create awareness among the people which is created a room for the market growth.


Europe commands the second largest immunoassay analyzer market, which is followed by Asia Pacific. Presence of huge patient pool, and increasing government support will drive the immunoassay analyzer market in Europe. Asia Pacific is the fastest growing region for the market due to the presence of a rapidly developing economies, and increasing need for the better treatment. China and India are the major contributor for the immunoassay analyzer market.


On the other hand, the Middle East & Africa has the least share in the immunoassay analyzer market due to presence of poor economy especially in Africa region. Middle East holds the major share in the Middle East & Africa immunoassay analyzer market owing to well-developed healthcare sector and huge healthcare expenditure. 


Key Players


Some of the major key player in the immunoassay analyzer market are F. Hoffmann-La Roche Ltd.  (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK). 


Market Assessment


Immunoassay Analyzers Market-


Source- World Health Organization (WHO), White Paper, Company Presentation, Annual Reports



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 1,588.16 Million
  CAGR   5.40%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Instruments, Applications, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK).
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of different infectious, immunological or metabolic diseases
  • Increasing demand of advanced diagnostic devices and recent trends of automation and integration


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Immunoassay analyzers market is expected to expand at 5.40% CAGR from 2022-2030.

    Rising demand of advanced diagnostic devices and increasing prevalence of chronic diseases are major drivers of the global immunoassay analyzers market.

    High costs of instruments and strict regulations pertaining to the approval of instruments can impede the global immunoassay analyzers market growth.

    The Americas can dominate the global immunoassay analyzers market due to the large number of diabetics.

    DiaSorin S.p., Siemens Ltd., Randox Laboratories Ltd., The Binding Site Group Ltd., F. Hoffmann-La Roche Ltd., Biokit S.A, Beckman Coulter, Inc., Olympus Corporation, Ortho Clinical Diagnostics, bioMérieux Private Limited, Abbott, Thermo Fisher Scientific, Nova Century Scientific, Inc., Merck KGaA, and Immunodiagnostic Systems are prominent players of the global immunoassay analyzers market.